Abnormal phenylalanine levels have a cumulative toxic effect on which body system?

The correct answer is d) Central nervous system.

Choice A reason:

The musculoskeletal system is not primarily affected by abnormal phenylalanine levels. Phenylketonuria (PKU) is a metabolic disorder that primarily impacts the brain and cognitive functions. While muscle weakness can occur due to overall health deterioration, it is not the primary system affected by phenylalanine toxicity.

Choice B reason:

The renal system is not the main target of phenylalanine toxicity. Although the kidneys play a role in filtering blood and excreting waste, the toxic effects of phenylalanine accumulation are more pronounced in the brain. Therefore, the renal system is not the primary system affected by abnormal phenylalanine levels.

Choice C reason:

The GI system, or gastrointestinal system, is not the primary system affected by abnormal phenylalanine levels. While dietary management is crucial for individuals with PKU to control phenylalanine intake, the toxic effects are primarily seen in the brain. The GI system is involved in the absorption and digestion of nutrients, but it is not the main system impacted by phenylalanine toxicity.

Choice D reason:

The central nervous system (CNS) is the primary system affected by abnormal phenylalanine levels. Phenylketonuria (PKU) leads to the accumulation of phenylalanine in the brain, causing severe brain damage and cognitive impairments. High levels of phenylalanine can disrupt neurotransmitter synthesis and brain development, leading to intellectual disabilities and other neurological issues. Therefore, the CNS is the main system impacted by phenylalanine toxicity.

Choice A reason:

Diabetes insipidus: Desmopressin acetate (DDAVP) is primarily used to treat central diabetes insipidus, a condition where the body lacks sufficient antidiuretic hormone (ADH) due to issues with the pituitary gland or hypothalamus. This hormone helps regulate water balance in the body, and desmopressin acts as a synthetic replacement to reduce frequent urination and excessive thirst.

Choice B Reason:

Acute adrenocortical insufficiency: This condition, also known as Addison’s disease, involves insufficient production of cortisol and aldosterone by the adrenal glands. Desmopressin is not used to treat this condition as it does not address the hormonal deficiencies involved.

Choice C Reason:

Hypopituitarism: This condition involves the underproduction of one or more hormones by the pituitary gland. While desmopressin can be used to manage specific symptoms related to ADH deficiency, it is not a comprehensive treatment for hypopituitarism, which requires hormone replacement therapy for multiple hormones.

Choice D Reason:

Syndrome of inappropriate antidiuretic hormone (SIADH): SIADH is characterized by excessive release of ADH, leading to water retention and hyponatremia. Desmopressin is not used to treat SIADH; in fact, it would exacerbate the condition by increasing ADH levels.